Entheon Biomedical Corp.
Entheon Biomedical Corp.
Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (“DMT Products”) for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
Entheon Biomedical Corp. (ENBI)
SEDAR Information
Company Info
Capitalization
Company Officers
Bulletins
2020-1111 – Fundamental Change - MPV Explorations Inc./Entheon Biomedical Corp.
le 11 novembre/November 2020
Entheon Biomedical Corp., the issuer resulting from a Fundamental Change of MPV Explorations Inc. (MPV), has been approved for listing.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
Advertisement
Publicité
